You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myelofibrosis

Showing 1 - 25 of 670
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Assess the Safety of Fedratinib in Korean Myelofibrosis

Recruiting
  • Primary Myelofibrosis
  • +2 more
  • Seoul, Korea, Republic of
    Bristol-Myers Squibb YH
Oct 3, 2023

68Ga-FAPI PET/CT Imaging for Diagnosis, Grading, and Efficacy

Recruiting
  • Primary Myelofibrosis
  • 68Ga FAPI PET/CT
  • Xiamen, Fujian, China
    Bing Xu
Nov 28, 2023

Real World Evidence of Fedratinib Effectiveness in MF

Not yet recruiting
  • Primary Myelofibrosis
  • +2 more
  • (no location specified)
May 22, 2023

Myelofibrosis, Moderate Thrombocytopenia Trial (Selinexor)

Not yet recruiting
  • Myelofibrosis
  • Moderate Thrombocytopenia
  • (no location specified)
Jul 31, 2023

Ruxolitinib in Patients With Myelofibrosis

Not yet recruiting
  • Myelofibrosis
  • (no location specified)
Feb 28, 2023

Pre-fibrotic Myelofibrosis Trial in Taipei, Taiwan, 100 (Ropeginterferon Alfa-2B Prefilled Syringe [Besremi])

Recruiting
  • Pre-fibrotic Myelofibrosis
  • Ropeginterferon Alfa-2B Prefilled Syringe [Besremi]
  • Taipei, Taiwan, 100, Taiwan
    National Taiwan University Hospital
Feb 7, 2023

Myelofibrosis (PMF), Post Essential Thrombocythemia Myelofibrosis (ET-MF), Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Not yet recruiting
  • Myelofibrosis (PMF)
  • +2 more
  • New York, New York
    Ruttenberg Treatment Center
Apr 18, 2023

Myelofibrosis Trial (Momelotinib)

Available
  • Myelofibrosis
  • (no location specified)
Oct 12, 2022

Assess Real-World Patient-Reported Outcomes With Fedratinib for

Recruiting
  • Myelofibrosis
    • City, State, Austria
      Local Institution
    Dec 16, 2022

    Myelofibrosis Trial in France (Clonal architecture determination)

    Not yet recruiting
    • Myelofibrosis
    • Clonal architecture determination
    • Angers, France
    • +6 more
    Jan 24, 2023

    Myelofibrosis; Anemia, Anemia, Myelofibrosis Trial in Canton, Gettysburg (DISC-0974)

    Recruiting
    • Myelofibrosis; Anemia
    • +5 more
    • Jacksonville, Florida
    • +6 more
    Jan 3, 2023

    Myeloproliferative Tumor, Polycythemia Vera, Essential Thrombocythemia Trial in Hong Kong

    Recruiting
    • Myeloproliferative Neoplasm
    • +7 more
      • Hong Kong, Hong Kong
        Department of Medicine, Queen Mary Hospital
      May 21, 2023

      Myelofibrosis Trial in Saint Louis (Fostamatinib, Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Saint Louis, Missouri
        Washington University School of Medicine
      Oct 26, 2022

      Myelofibrosis Trial in Hangzhou (Jaktinib Hydrochloride Tablets)

      Recruiting
      • Myelofibrosis
      • Jaktinib Hydrochloride Tablets
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital of Medical School of Zhejiang Univ
      Nov 28, 2022

      Myelofibrosis Trial in Hangzhou (Jaktinib, Placebo to match Hydroxycarbamide, Hydroxycarbamide Tablets)

      Recruiting
      • Myelofibrosis
      • Hangzhou, Zhejiang, China
        The First Affiliated Hospital of Medical School of Zhejiang Univ
      Nov 28, 2022

      Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase, Primary Myelofibrosis, Secondary Myelofibrosis Trial in Houston

      Completed
      • Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase
      • +2 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      May 27, 2022

      Myelofibrosis Trial in Hong Kong (Bomedemstat)

      Recruiting
      • Myelofibrosis
      • Hong Kong, Hong Kong
        Department of Medicine, the University of Hong Kong, Queen Mary
      Oct 3, 2022

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, ET-MF Trial in New York (Canakinumab)

      Recruiting
      • Primary Myelofibrosis
      • +4 more
      • New York, New York
        Ruttenberg Treatment Center
      Jul 18, 2022

      Myelofibrosis Trial in Houston (Long-term Follow-up, Quality-of-Life Assessment, Ruxolitinib)

      Active, not recruiting
      • Myelofibrosis
      • Long-term Follow-up
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Sep 7, 2022

      Myelofibrosis Trial in Paris (Ruxolotinib)

      Completed
      • Myelofibrosis
      • Paris, France
        ROBIN
      Jul 26, 2022

      Myelofibrosis Trial in Canton (Jaktinib Hydrochloride Tablet)

      Recruiting
      • Myelofibrosis
      • Jaktinib Hydrochloride Tablet
      • Canton, Ohio
        Site 01
      Aug 18, 2022

      Primary Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis Trial in Ipoh (NS-018,

      Recruiting
      • Primary Myelofibrosis
      • +2 more
      • Worcester, Massachusetts
      • +16 more
      Oct 31, 2022

      Myelodysplastic/Myeloproliferative Tumor, Unclassifiable, Myelofibrosis Transformation in Essential Thrombocythemia,

      Recruiting
      • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
      • +3 more
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 18, 2022

      Myelofibrosis Trial in United States (Ruxolitinib)

      Recruiting
      • Myelofibrosis
      • Boston, Massachusetts
      • +4 more
      Oct 21, 2022

      Myelofibrosis Trial in Salt Lake City (Pegylated interferon alpha2a)

      Not yet recruiting
      • Myelofibrosis
      • Pegylated interferon alpha2a
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Sep 6, 2022